Clinical Trials Logo

Clinical Trial Summary

Quantitative MRI scanning parameters such as T1 mapping, T2 mapping, T1ρ, and elastography are used, combined with clinical and laboratory indicators, to predict the risk of liver cancer in patients with cirrhosis.


Clinical Trial Description

Retrospectively and prospectively collect T1 mapping, T2 mapping, T2* mapping, T1ρ, elastography and other multi-parameter MRI sequence images and clinical and laboratory examination data from patients with liver cirrhosis, and conduct 5-year clinical follow-up and monitoring of all enrolled patients. Whether patients develop hepatocellular carcinoma, patients are divided into liver cancer occurrence group and non-hepatocellular carcinoma group according to clinical follow-up results. Cox proportional hazard analysis is used to compare the differences in clinical characteristics, laboratory tests, imaging characteristics, quantitative MRI parameters and other variables between the two groups of patients. , and calculate the hazard ratio for each variable; assign a score to each covariate based on the proportion of the hazard ratio in the multivariable model, and develop a nomogram to predict HCC risk by the total score. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06060769
Study type Observational
Source Fifth Affiliated Hospital, Sun Yat-Sen University
Contact Yaqin Zhang, MD, Ph.D
Phone 13719282895
Email zhyaqin@mail.sysu.edu.cn
Status Recruiting
Phase
Start date September 1, 2023
Completion date January 31, 2029